Lääketiede

A study has identified how an existing medication could improve immunotherapy outcomes for fibrolamellar carcinoma. The rare liver cancer currently has no cure and often spreads before detection. Researchers demonstrated the approach using patient tumor samples.

24. kesäkuuta 2026 Raportoinut AI Faktatarkistettu

A Newcastle University-led screening study of nearly 300 adults in northern Britain found persistently high rates of low vitamin D in older people and adults from minoritized ethnic groups, with little evidence that summer months substantially improved levels.

Researchers at the University of California, Riverside have proposed that amyloid beta disrupts tau protein function inside neurons, potentially triggering Alzheimer's disease. The findings challenge the focus on external plaques as the primary cause.

17. kesäkuuta 2026 Raportoinut AI

Two existing medications cooled core body temperature in animals after stroke and reduced brain damage. A small human trial showed limited effect due to slow delivery. Researchers are now planning a follow-up study with faster infusions.

Lundilainen lääketieteellisen teknologian yritys SpectraCure toteuttaa merkintäoikeusannin, jolla kerätään 34,2 miljoonaa kruunua, mikäli anti merkitään täysimääräisesti. Annilla rahoitetaan kliinisiä tutkimuksia ja viranomaislupahakemuksia. Yhtiön osake laski maanantaina yli 20 prosenttia.

14. kesäkuuta 2026 Raportoinut AI Faktatarkistettu

Adults with obesity who began taking GLP-1 receptor agonist medications showed declines in Fitbit-measured physical activity after starting treatment, according to a retrospective study presented Saturday at ENDO 2026, the Endocrine Society’s annual meeting in Chicago.